Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Net income margin (%)

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Apr 30, 2024-100.6-26915.05%
Apr 30, 20230.4-99.65%
Apr 30, 2022106.8+812.78%
Apr 30, 202111.7-166.71%
Apr 30, 2020-17.5+122.94%
Apr 30, 2019-7.9-80.67%
Apr 30, 2018-40.7-16.74%
Apr 30, 2017-48.9-60.77%
Apr 30, 2016-124.5-33.77%
Apr 30, 2015-188+19.12%
Apr 30, 2014-157.9+14.94%
Apr 30, 2013-137.3-50.33%
Apr 30, 2012-276.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat